| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ofranergene obadenovec | VB-111; GT-111 | Phase 3 Clinical | Vascular Pharmaceuticals Inc | Ovarian Neoplasms; Thyroid Carcinoma, Anaplastic; Neoplasms; Glioblastoma; Neuroendocrine Tumors; Colorectal Neoplasms | Details |
| Atrosab | Phase 1 Clinical | Celonic | Inflammation | Details |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



